We report a case of propylthiouracil (PTU)-induced cholestatic hepatot
oxicity in Graves' disease that developed 1 day after beginning PTU. A
fter clinical recovery, liver abnormalities persisted for 5 years. Per
cutaneous liver biopsy and the eventual normalization of enzyme levels
excluded permanent liver damage as a result of PTU therapy. Thus prol
onged elevation of serum enzymes is consistent with the diagnosis of P
TU-induced hepatotoxicity, which may recover completely.